-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on CVS Health, Lowers Price Target to $118

Benzinga·09/03/2026 15:31:53
语音播报
UBS analyst Kevin Caliendo maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $126 to $118.